MARC Record from marc_columbia

LEADER: 06562cam a2200937 i 4500
001 15130669
005 20220219230934.0
006 m o d
007 cr cnu|||unuuu
008 180222s2018 flu ob 001 0 eng d
035 $a(OCoLC)on1023861521
035 $a(NNC)15130669
040 $aN$T$beng$erda$epn$cN$T$dN$T$dOCLCF$dEBLCP$dNLE$dERL$dMERER$dOCLCQ$dUKMGB$dOCLCO$dOCLCA$dOCLCQ$dTYFRS$dOCLCA$dAU@$dOCLCQ$dOCLCO$dOCLCQ$dOCLCA$dK6U$dOCLCO$dNLW$dOCLCO$dOCLCQ
015 $aGBB844470$2bnb
015 $aGBB8I3956$2bnb
016 7 $a018738116$2Uk
016 7 $a019050268$2Uk
019 $a1031041359
020 $a9781351082242$q(electronic bk.)
020 $a1351082248$q(electronic bk.)
020 $a9781351073790
020 $a1351073796
020 $a9781351099141
020 $a1351099140
020 $a9781351090698
020 $a1351090690
020 $z9781315894690
024 7 $a10.1201/9781351073790$2doi
035 $a(OCoLC)1023861521$z(OCoLC)1031041359
037 $a9781351082242$bIngram Content Group
050 4 $aRC271.I45
072 7 $aHEA$x039000$2bisacsh
072 7 $aMED$x014000$2bisacsh
072 7 $aMED$x022000$2bisacsh
072 7 $aMED$x112000$2bisacsh
072 7 $aMED$x045000$2bisacsh
082 04 $a616.99/4061$223
049 $aZCUA
245 00 $aInterleukin-2 and killer cells in cancer /$ceditor, Eva Lotzová ; associate editor, Ronald B. Herberman.
264 1 $aBoca Raton, FL :$bCRC Press,$c2018.
300 $a1 online resource
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aCRC revivals
504 $aIncludes bibliographical references and index.
520 $aThis is the first-and only-publication available which provides the most recent information in this particular field of biomedicine. Interleukin-2 (IL-2) and IL-2 activated killer cells have been shown to have a potential in the treatment of a variety of human malignant diseases. This work comprehensively summarizes basic aspects of IL-2 as well as its clinical application, therefore making all these aspects easily accessible to the readers. Because of the clinical significance of this molecule in the treatment of cancer, the basic and clinical investigations in the IL-2 field are rapidly expanding, together with the interest of the scientific and medical community. This book is an excellent educational and teaching tool for scientists, clinicians, and students. Those who already have expertise in research in the IL-2 area will find this reference indispensible.
588 0 $aOnline resource; title from PDF title page (EBSCO, viewed February 26, 2018).
505 0 $aCover; Title Page; Copyright Page; Preface; The Editor; Associate Editor; Dedication; Contributors; Table of Contents; Chapter 1 Cellular Immunotherapy of Cancer: Preclinical and Clinical Testing UtilizingInter leukin-2; Chapter 2 Long-Term Culture of IL-2 Generated Killer Cells with Antitumor Activity; Chapter 3 Function of Interleukin-2 Activated NK Cells in Leukemia Resistance and Treatment; Chapter 4 Utilizing Lymphokine-Activated Killer Cells for Bone Marrow Purging; Chapter 5 Cell-Mediated Cytotoxicity Against Fresh Solid Tumor Cells: Regulation by Soluble Mediators
505 8 $aChapter 6 Down-Regulation of Human Bone Marrow Cells and Their Progenitors by IL-2-Activated LymphocytesChapter 7 IL-2-Induced Cytotoxic Cells from Human Thymocytes; Chapter 8 Regulation of NK Cytotoxicity In Vivo in Patients Receiving IL-2; Chapter 9 Synergism between Cyclophosphamide and Interleukin-2; Chapter 10 Human Tumor-Infiltrating Lymphocytes and Their Characterization; Chapter 11 Growth Kinetics, Function, and Characterization of Lymphocytes Infiltrating Ovarian Tumors
505 8 $aChapter 12 Cancer Treatment Using IL-2-Activated Killer Cells and/or IL-2 in Combination with Chemotherapeutic DrugsChapter 13 Development of Adoptive Immunotherapy with In Vitro Sensitized T Lymphocytes from Mice Bearing Progressively Growing Tumors; Chapter 14 Adoptive Transfer of T Cells for Therapy of Disseminated Leukemia: Antigen Specificity and Function of Tumor-Reactive T Cells; Chapter 15 LAK Cells and Autologous Bone Marrow Transplantation: Toward a Cure for Leukemia
505 8 $aChapter 16 Tumor Inhibitory Effects of Regional Interleukin-2 Administration and the Role of Lymphokine-Activated Killer CellsChapter 17 Tissue Distribution and Localization of IL-2-Activated Killer Cells after Adoptive Transfer In Vivo; Chapter 18 In Vivo Tissue Distribution of Interleukin-2-Activated Cells; Chapter 19 Role of rIL-2 in Host Resistance Against Cryptococcal Infection; Chapter 20 Role of IL-2 in Growth and Differentiation of Cryptotoxic Cells; Chapter 21 The Interleukin-2 Receptor Complex and Its Role in the Induction of Nonspecific Cytotoxicity
505 8 $aChapter 22 Regulation of Phosphorylation and Gene Expression in Cytotoxic Lymphocytes by Interleukin-2Chapter 23 Role of the Interleukin-2 Receptor in the Growth and Regulation of LAK Activity; Chapter 24 Surface Structures Involved in Tumor Cell Recognition by Fresh and IL-2-Activated Natural Killer Cells; Index
650 0 $aCancer$xImmunotherapy.
650 0 $aKiller cells.
650 0 $aInterleukin-2$xTherapeutic use.
650 2 $aInterleukin-2$xtherapeutic use
650 2 $aKiller Cells, Natural$ximmunology
650 2 $aNeoplasms$xtherapy
650 7 $aHEALTH & FITNESS$xDiseases$xGeneral.$2bisacsh
650 7 $aMEDICAL$xClinical Medicine.$2bisacsh
650 7 $aMEDICAL$xDiseases.$2bisacsh
650 7 $aMEDICAL$xEvidence-Based Medicine.$2bisacsh
650 7 $aMEDICAL$xInternal Medicine.$2bisacsh
650 7 $aCancer$xImmunotherapy.$2fast$0(OCoLC)fst00845386
650 7 $aInterleukin-2$xTherapeutic use.$2fast$0(OCoLC)fst00976423
650 7 $aKiller cells.$2fast$0(OCoLC)fst00987504
650 7 $aInterleukines$xusage thérapeutique.$2fmesh
650 7 $aCellules tueuses$ximmunologie.$2fmesh
650 7 $aTumeurs$xThérapeutique.$2fmesh
650 7 $aKrebs$gMedizin$2gnd
650 7 $aInterleukine$2gnd
650 7 $aKillerzelle$2gnd
650 7 $aAufsatzsammlung$2gnd
655 4 $aElectronic books.
700 1 $aLotzová, Eva,$d1936-$eeditor.
700 1 $aHerberman, Ronald B.,$d1940-
776 08 $iPrint version:$z9781315894690
830 0 $aCRC revivals.
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio15130669$zTaylor & Francis eBooks
852 8 $blweb$hEBOOKS